Katrina Walker

507 citations

18 papers · 275 indexed · h-index 9

Impact in

Hematology top 10%
- Multiple Myeloma Research and Treatments
Rehabilitation top 10%
- Stroke Rehabilitation and Recovery

Papers in ⓘ

Hematology 11
- Multiple Myeloma Research and Treatments 11
Rehabilitation 3
- Stroke Rehabilitation and Recovery 3

Co-authors: Sandra Brauer (3 shared papers)Alana Campbell (3 shared papers)Rohan Grimley (3 shared papers)Kathryn S. Hayward (3 shared papers)Heidi Janssen (2 shared papers)Ingrid Rosbergen (3 shared papers)Sarah Brown (13 shared papers)Martin Kaiser (11 shared papers)
Journals: Blood (5 papers)Journal of Clinical Oncology (2 papers)BMJ Open (1 paper)Clinical Rehabilitation (1 paper)Parkinson s Disease (1 paper)
Partner nations: United Kingdom Australia United States

In The Last Decade

Katrina Walker

18 papers receiving 271 citations

Peers

Countries citing papers authored by Katrina Walker

Since Specialization

Citations

This map shows the geographic impact of Katrina Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrina Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrina Walker more than expected).

Fields of papers citing papers by Katrina Walker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrina Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrina Walker. The network helps show where Katrina Walker may publish in the future.

Co-authors

The 25 scholars most cited alongside Katrina Walker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Katrina Walker Line = papers co-authored together Katrina Walker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Embedding an enriched environment in an acute stroke unit increases activity in people with stroke: a controlled before–after pilot study Clinical Rehabilitation ·Ingrid Rosbergen, Rohan Grimley, Kathryn S. Hayward, Katrina Walker, Donna Rowley, Alana Campbell, Suzanne McGufficke, Samantha Robertson, J. Trinder, Heidi Janssen, Sandra Brauer	2017	92
2	Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma Journal of Clinical Oncology ·Martin Kaiser, Andrew Hall, Katrina Walker, Amy L. Sherborne, Ruth M. de Tute, Nicola Newnham, Sadie Roberts, Emma Ingleson, Kristian M. Bowles, Mamta Garg, Anand Lokare, Christina Messiou, Richard S. Houlston, Graham Jackson, Gordon Cook, Guy Pratt, Roger G. Owen, Mark T. Drayson, Sarah Brown, Matthew Jenner	2023	54
3	Abdominal Massage for the Relief of Constipation in People with Parkinson’s: A Qualitative Study Parkinson s Disease ·Doreen McClurg, Katrina Walker, Pam Aitchison, Katharine Jamieson, Louise Dickinson, Lorna Paul, Suzanne Hagen, AnneLouise Cunnington	2016	24
4	The effect of an enriched environment on activity levels in people with stroke in an acute stroke unit: protocol for a before-after pilot study Pilot and Feasibility Studies ·Ingrid Rosbergen, Rohan Grimley, Kathryn S. Hayward, Katrina Walker, Donna Rowley, Alana Campbell, Suzanne McGufficke, Samantha Robertson, J. Trinder, Heidi Janssen, Sandra Brauer	2016	19
5	Early phase clinical trials extension to guidelines for the content of statistical analysis plans BMJ ·Victoria Homer, Christina Yap, Simon Bond, Jane Holmes, Deborah Stocken, Katrina Walker, Emily Robinson, Graham Wheeler, Sarah Brown, Samantha Hinsley, Matthew J. Schipper, Christopher J. Weir, Khadija Rantell, Thomas J. Prior, Ly‐Mee Yu, John Kirkpatrick, Alun Bedding, Carrol Gamble, Piers Gaunt	2022	17
6	MUK nine OPTIMUM protocol: a screening study to identify high-risk patients with multiple myeloma suitable for novel treatment approaches combined with a phase II study evaluating optimised combination of biological therapy in newly diagnosed high-risk multiple myeloma and plasma cell leukaemia BMJ Open ·Sarah Brown, Debbie Sherratt, Samantha Hinsley, Louise Flanagan, Sadie Roberts, Katrina Walker, Andrew Hall, Guy Pratt, Christina Messiou, Matthew Jenner, Martin Kaiser	2021	17
7	Depth of response and minimal residual disease status in ultra high-risk multiple myeloma and plasma cell leukemia treated with daratumumab, bortezomib, lenalidomide, cyclophosphamide and dexamethasone (Dara-CVRd): Results of the UK optimum/MUKnine trial. Journal of Clinical Oncology ·Martin Kaiser, Andrew Hall, Katrina Walker, Ruth de Tute, Sadie Roberts, Emma Ingleson, Kristian M. Bowles, Mamta Garg, Anand Lokare, Christina Messiou, Graham Jackson, Guy Pratt, Gordon Cook, Mark T. Drayson, Roger G. Owen, Sarah Brown, Matthew Jenner	2021	11
8	Ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory myeloma: MUKeight phase II randomised controlled trial results Blood Cancer Journal ·Holger W. Auner, Sarah Brown, Katrina Walker, Jessica Kendall, Bryony Dawkins, David Meads, Gareth J. Morgan, Martin Kaiser, Mark Cook, Sadie Roberts, Christopher Parrish, Gordon Cook	2022	10
9	Cyclophosphamide Exerts Significant Immunomodulatory Function in Myeloma Patients Treated with Pomalidomide and Dexamethasone Blood ·James Croft, Andrew Hall, Katrina Walker, Amy L. Sherborne, Kevin Boyd, Mamta Garg, Charlotte Pawlyn, Debbie Sherratt, Sadie Reed, William E. Pierceall, Gordon Cook, Anjan Thakurta, Sarah Brown, Martin Kaiser	2018	8
10	Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, Dexamethasone (Dara-CVRd), V-Augmented Autologous Stem Cell Transplant (V-ASCT) and Dara-Vrd Consolidation in Ultra-High Risk (UHiR) Newly Diagnosed Myeloma (NDMM) and Primary Plasma Cell Leukemia (pPCL) Compared with Myeloma XI/XI+ Trial Treatment for Uhir MM: The UK Optimum/Muknine Trial Blood ·Martin Kaiser, Andrew Hall, Katrina Walker, Nicola Newnham, Ruth M. de Tute, Sadie Roberts, Emma Ingleson, Kristian M. Bowles, Mamta Garg, Anand Lokare, Christina Messiou, Graham Jackson, Gordon Cook, Guy Pratt, Roger G. Owen, Mark T. Drayson, Sarah Brown, Matthew Jenner	2021	8
11	Prognostic Molecular Stratification in Relapsed/Refractory Multiple Myeloma - Results of the Pomalidomide Mukseven (NCT02406222) Biomarker Trial Blood ·James Croft, Andrew Hall, Amy L. Sherborne, Katrina Walker, Sidra Ellis, Kim A. Sharp, Amy Price, Charlotte Pawlyn, Louise Flanagan, Mamta Garg, Suzana S. Couto, Maria Wang, Kevin Boyd, William E. Pierceall, Anjan Thakurta, Gordon Cook, Sarah Brown, Martin Kaiser	2019	4
12	The MUK eight protocol: a randomised phase II trial of cyclophosphamide and dexamethasone in combination with ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients who have relapsed after treatment with thalidomide, lenalidomide and a proteasome inhibitor Trials ·Samantha Hinsley, Katrina Walker, Debbie Sherratt, Lucy Bailey, Sadie Reed, Louise Flanagan, Sophie C. McKee, Fiona Brudenell Straw, Bryony Dawkins, David Meads, Holger W. Auner, Martin Kaiser, Mark Cook, Sarah Brown, Gordon Cook	2020	3
13	Implementation of the Time-to-Event Continuous Reassessment Method Design in a Phase I Platform Trial Testing Novel Radiotherapy-Drug Combinations—CONCORDE JCO Precision Oncology ·Katrina Walker, Samantha Hinsley, Rachel Phillip, Jamie B. Oughton, Geraldine Murden, Anthony J. Chalmers, Corinne Faivre‐Finn, Alastair Greystoke, Sarah Brown, (unknown)	2022	2
14	Cyclophosphamide, Pomalidomide and Dexamethasone Significantly Improves Response over Poma/Dex in Relapsed/Refractory Myeloma Patients Previously Treated with Cyclophosphamide Combination Therapy - Initial Results of the Randomised Multicentre Mukseven Trial Blood ·James Croft, Andrew Hall, Katrina Walker, Amy L. Sherborne, Sidra Ellis, Amy Price, Debbie Sherratt, Sadie Reed, Charlotte Pawlyn, Mamta Garg, Kevin Boyd, Gordon Cook, Sarah Brown, Martin Kaiser	2018	2
15	Feasibility of creating an enriched environment and subsequent impact on activity levels for stroke patients in an acute stroke unit: A study protocol International Journal of Stroke ·Ingrid Rosbergen, Rohan Grimley, Kathryn S. Hayward, Katrina Walker, Donna Rowley, Alana Campbell, Suzanne McGufficke, Samantha Robertson, J. Trinder, Sandra Brauer	2014	1
16	Starting priority radiotherapy treatments more quickly Clinical Oncology ·D. Holyoake, Gillian C. Barnett, Richard Benson, Sarah Jefferies, J. Chapman, Kevin Skilton, N. Twyman, Katrina Walker, M.V. Williams	2015	1
17	Molecular Treatment Stratification for Newly Diagnosed High-Risk Myeloma, Including Plasma Cell Leukemia - Feasibility Results of the Ukmra Optimum: MUK9 Trial (NCT03188172) Blood ·Matthew Jenner, Amy L. Sherborne, Andrew Hall, Vallari Shah, Katrina Walker, Sidra Ellis, Kim A. Sharp, Amy Price, James Croft, Graham Jackson, Louise Flanagan, Mark T. Drayson, Ruth M. de Tute, Roger G. Owen, Guy Pratt, Gordon Cook, Sarah Brown, Martin Kaiser	2019	1
18	OAB-012: Depth of response and MRD in newly diagnosed ultra high-risk myeloma and plasma cell leukemia treated with Dara-CVRd and V-MEL ASCT: results of the molecularly stratified UK OPTIMUM/MUKnine trial Clinical Lymphoma Myeloma & Leukemia ·Martin Kaiser, Andrew Hall, Katrina Walker, Ruth de Tute, Sadie Roberts, Emma Ingleson, Kristian M. Bowles, Mamta Garg, Anand Lokare, Christina Messiou, Graham Jackson, Guy Pratt, Gordon Cook, Mark T. Drayson, Roger G. Owen, Sarah Brown, Matthew Jenner	2021	1

About Katrina Walker

Katrina Walker is a scholar working on Hematology, Rehabilitation, Genetics, Statistics and Probability and Oncology, having authored 18 papers that have together received 275 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (11 papers), Protein Degradation and Inhibitors (8 papers), Stroke Rehabilitation and Recovery (3 papers), Cancer Treatment and Pharmacology (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Acute Ischemic Stroke Management (2 papers), Cancer Mechanisms and Therapy (2 papers) and Statistical Methods in Clinical Trials (2 papers). The work is most often cited by research in Hematology (114 citations), Rehabilitation (62 citations), Physical Therapy, Sports Therapy and Rehabilitation (15 citations), Complementary and Manual Therapy (6 citations) and Neurology (21 citations). Katrina Walker has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Sandra Brauer, Alana Campbell, Rohan Grimley, Kathryn S. Hayward, Heidi Janssen, Ingrid Rosbergen, Sarah Brown, Martin Kaiser, Gordon Cook and Andrew Hall. Their work appears in journals such as Blood, Journal of Clinical Oncology, BMJ Open, Clinical Rehabilitation and Parkinson s Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact